Global Solid Lipid Nanoparticles Market Growth 2025-2031
Description
The global Solid Lipid Nanoparticles market size is predicted to grow from US$ 660 million in 2025 to US$ 1482 million in 2031; it is expected to grow at a CAGR of 14.4% from 2025 to 2031.
The impact of the latest U.S. tariff measures and the corresponding policy responses from countries worldwide on market competitiveness, regional economic performance, and supply chain configurations will be comprehensively evaluated in this report.
Solid lipid nanoparticles are a type of nanoscale drug delivery carrier made of biocompatible and degradable solid lipids, usually with a particle size of 50-1000 nanometers. They remain solid at room temperature and body temperature, can encapsulate hydrophobic or hydrophilic active substances, have good physical stability, controlled release, biocompatibility and low toxicity, and are widely used in the delivery systems of drugs, cosmetics and functional foods.
United States market for Solid Lipid Nanoparticles is estimated to increase from US$ million in 2024 to US$ million by 2031, at a CAGR of % from 2025 through 2031.
China market for Solid Lipid Nanoparticles is estimated to increase from US$ million in 2024 to US$ million by 2031, at a CAGR of % from 2025 through 2031.
Europe market for Solid Lipid Nanoparticles is estimated to increase from US$ million in 2024 to US$ million by 2031, at a CAGR of % from 2025 through 2031.
Global key Solid Lipid Nanoparticles players cover Evonik Industries, Merck, Gattefossé, Croda International, PharmaSol GmbH, etc. In terms of revenue, the global two largest companies occupied for a share nearly % in 2024.
LP Information, Inc. (LPI) ' newest research report, the “Solid Lipid Nanoparticles Industry Forecast” looks at past sales and reviews total world Solid Lipid Nanoparticles sales in 2024, providing a comprehensive analysis by region and market sector of projected Solid Lipid Nanoparticles sales for 2025 through 2031. With Solid Lipid Nanoparticles sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Solid Lipid Nanoparticles industry.
This Insight Report provides a comprehensive analysis of the global Solid Lipid Nanoparticles landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Solid Lipid Nanoparticles portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global Solid Lipid Nanoparticles market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Solid Lipid Nanoparticles and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Solid Lipid Nanoparticles.
This report presents a comprehensive overview, market shares, and growth opportunities of Solid Lipid Nanoparticles market by product type, application, key manufacturers and key regions and countries.
Segmentation by Type:
Traditional Solid Lipid Nanoparticles
Nanostructured Lipid Carriers
Others
Segmentation by Application:
Pharmaceutical Industry
Cosmetic Industry
Agricultural Industry
Others
This report also splits the market by region:
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries
The below companies that are profiled have been selected based on inputs gathered from primary experts and analysing the company's coverage, product portfolio, its market penetration.
Evonik Industries
Merck
Gattefossé
Croda International
PharmaSol GmbH
Nanovex Biotechnologies
CordenPharma
Nanoform Finland
Cytiva
BioDuro-Sundia
Key Questions Addressed in this Report
What is the 10-year outlook for the global Solid Lipid Nanoparticles market?
What factors are driving Solid Lipid Nanoparticles market growth, globally and by region?
Which technologies are poised for the fastest growth by market and region?
How do Solid Lipid Nanoparticles market opportunities vary by end market size?
How does Solid Lipid Nanoparticles break out by Type, by Application?
Please note: The report will take approximately 2 business days to prepare and deliver.
The impact of the latest U.S. tariff measures and the corresponding policy responses from countries worldwide on market competitiveness, regional economic performance, and supply chain configurations will be comprehensively evaluated in this report.
Solid lipid nanoparticles are a type of nanoscale drug delivery carrier made of biocompatible and degradable solid lipids, usually with a particle size of 50-1000 nanometers. They remain solid at room temperature and body temperature, can encapsulate hydrophobic or hydrophilic active substances, have good physical stability, controlled release, biocompatibility and low toxicity, and are widely used in the delivery systems of drugs, cosmetics and functional foods.
United States market for Solid Lipid Nanoparticles is estimated to increase from US$ million in 2024 to US$ million by 2031, at a CAGR of % from 2025 through 2031.
China market for Solid Lipid Nanoparticles is estimated to increase from US$ million in 2024 to US$ million by 2031, at a CAGR of % from 2025 through 2031.
Europe market for Solid Lipid Nanoparticles is estimated to increase from US$ million in 2024 to US$ million by 2031, at a CAGR of % from 2025 through 2031.
Global key Solid Lipid Nanoparticles players cover Evonik Industries, Merck, Gattefossé, Croda International, PharmaSol GmbH, etc. In terms of revenue, the global two largest companies occupied for a share nearly % in 2024.
LP Information, Inc. (LPI) ' newest research report, the “Solid Lipid Nanoparticles Industry Forecast” looks at past sales and reviews total world Solid Lipid Nanoparticles sales in 2024, providing a comprehensive analysis by region and market sector of projected Solid Lipid Nanoparticles sales for 2025 through 2031. With Solid Lipid Nanoparticles sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Solid Lipid Nanoparticles industry.
This Insight Report provides a comprehensive analysis of the global Solid Lipid Nanoparticles landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Solid Lipid Nanoparticles portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global Solid Lipid Nanoparticles market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Solid Lipid Nanoparticles and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Solid Lipid Nanoparticles.
This report presents a comprehensive overview, market shares, and growth opportunities of Solid Lipid Nanoparticles market by product type, application, key manufacturers and key regions and countries.
Segmentation by Type:
Traditional Solid Lipid Nanoparticles
Nanostructured Lipid Carriers
Others
Segmentation by Application:
Pharmaceutical Industry
Cosmetic Industry
Agricultural Industry
Others
This report also splits the market by region:
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries
The below companies that are profiled have been selected based on inputs gathered from primary experts and analysing the company's coverage, product portfolio, its market penetration.
Evonik Industries
Merck
Gattefossé
Croda International
PharmaSol GmbH
Nanovex Biotechnologies
CordenPharma
Nanoform Finland
Cytiva
BioDuro-Sundia
Key Questions Addressed in this Report
What is the 10-year outlook for the global Solid Lipid Nanoparticles market?
What factors are driving Solid Lipid Nanoparticles market growth, globally and by region?
Which technologies are poised for the fastest growth by market and region?
How do Solid Lipid Nanoparticles market opportunities vary by end market size?
How does Solid Lipid Nanoparticles break out by Type, by Application?
Please note: The report will take approximately 2 business days to prepare and deliver.
Table of Contents
87 Pages
- *This is a tentative TOC and the final deliverable is subject to change.*
- 1 Scope of the Report
- 2 Executive Summary
- 3 Global by Company
- 4 World Historic Review for Solid Lipid Nanoparticles by Geographic Region
- 5 Americas
- 6 APAC
- 7 Europe
- 8 Middle East & Africa
- 9 Market Drivers, Challenges and Trends
- 10 Manufacturing Cost Structure Analysis
- 11 Marketing, Distributors and Customer
- 12 World Forecast Review for Solid Lipid Nanoparticles by Geographic Region
- 13 Key Players Analysis
- 14 Research Findings and Conclusion
Pricing
Currency Rates
Questions or Comments?
Our team has the ability to search within reports to verify it suits your needs. We can also help maximize your budget by finding sections of reports you can purchase.
